Arrayit Corp.OTCPK - Limited
Sep. 12, 2014, 11:43 AM
- Arrrayit Corp. (OTCQB:ARYC +1.6%) settles its legal dispute with Avant Diagnostics by mutual agreement. Arrayit will maintain its exclusive right to manufacture OvaDx for Avant until such time as the rights are sold to a third party. Avant's outstanding invoice of $1.55M due Arrayit will be settled by the issuance of 10M Avant shares to Arrayit. The companies will also swap 10M shares between the two.